F10.2
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: alcohol dependence, staying abstinent from alcohol for at least five days
Exclusion criteria
Exclusion criteria: oral administration of a beta-blocker within 14 days prior to study begin, oral administration of antidepressants within three months prior to study begin, oral administration of anticoagulants within 14 days prior to study begin, diabetis mellitus, coronary heart disease, heart failure, dementia, schizophrenia, major depression or bipolar disorder, drug addiction, known metal allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| heart rate variabilty (analysis of ECG and pulse wave) 3 time points of measurement: before start of first treatment and on the last treatment day as well as four weeks afterwards | — |
Secondary
| Measure | Time frame |
|---|---|
| craving, anxiety, depression, psychic symptom load, relaxation, skin condunctance, skin blood flow Psychometric questionaires, skin resistance, photopletysmography 3 time points of measurement: before start of first treatment and on the last treatment day as well as four weeks afterwards | — |
Countries
Germany
Contacts
Fachklinik Weinböhla